Alkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is available under brand names like Semasize and Obesema. The injection is administered once weekly. Alkem offers a pre-fil…
Alkem Laboratories on Saturday said it has launched semaglutide injection in India, entering the fast-growing market for diabetes and weight loss drug with a product priced at a starting weekly cost … [+2619 chars]
